UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000011457
Receipt No. R000013413
Scientific Title Phase II trial of induction mFOLFOX6 plus Avastin followed by neoaduvant chemoradiotherapy with TS-1 for MRI-defined high-risk rectal cancer (IMPACT-RC)
Date of disclosure of the study information 2013/08/11
Last modified on 2019/07/08 15:27:50

No. Disposal Last modified on Item of update
1 Insert 2013/08/11 23:11:30
2 Update 2014/03/11 10:16:49 Target sample size
3 Update 2015/03/11 09:34:38 TEL
Email
Last name of contact person
Last name of contact person
TEL
Email
4 Update 2015/09/11 09:18:29 Key secondary outcomes
Key secondary outcomes
5 Update 2015/09/11 09:19:09 Target sample size
6 Update 2015/09/23 02:03:38 Target sample size
7 Update 2015/09/23 02:08:30 Other related information
Other related information
8 Update 2015/09/23 02:10:57 Other related information
9 Update 2018/02/15 00:25:40 Recruitment status
Publication of results
10 Update 2019/07/08 15:22:39 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Name of primary sponsor
Organization
Organization
Category of Funding Organization
Nationality of Funding Organization
Nationality of Funding Organization
Organization
Organization
Address
Address
Tel
Email
11 Update 2019/07/08 15:23:35 Number of participants that the trial has enrolled
12 Update 2019/07/08 15:27:50 Recruitment status
Date of IRB
Last follow-up date


Contact us.